Summary
Aware reported a sharp second-quarter increase in revenue and operating income for the period ended June 30, 2014. Revenue rose 52.9% to $6.77 million from the prior-year quarter. Year-to-date revenue was $13.38 million, up 42.3% from the first six months of 2013. Operating income reached $1.38 million, up 388.3% from the prior-year quarter. Operating margin was 20.4%, up from 6.4% a year earlier. Net income for the quarter was $0.86 million, up 181.8%, and diluted EPS was $0.04, up 300.0%.
Those quarterly gains contrast with the year-to-date bottom line. Net income for the six months ended June 30, 2014 was $1.75 million, down 19.3% from the prior-year period. Diluted EPS for the year to date was $0.08, down 20.0%. The company attributed the year-to-date decline to prior-year patent arrangement income that did not repeat in 2014. Operating income before patent-related income was approximately the same in both six-month periods. The quarterly revenue mix also shifted. Software license revenue rose on an international biometrics sale and higher medical imaging usage. Services revenue grew on a significant U.S. government project. Hardware sales increased on more units ordered by a single U.S. government customer. Royalties declined, and management expects royalties to fall in future quarters.
Cash generation weakened even as reported earnings improved. Operating cash flow was $1.48 million in the second quarter, down 59.2% from the prior-year quarter. For the first six months, operating cash flow was $2.68 million, down 37.0% from the prior-year period. Capital expenditures were $0.09 million in the quarter, up 125.0%, and $0.10 million year to date, down 8.2%. Deferred revenue, current portion only, was $2.12 million at June 30, 2014, down 32.3% from the prior-year quarter. The deferred revenue decline may reflect the timing of billings and contract renewals, but it is a metric worth monitoring because it can signal future revenue recognition pressure. The gap between net income and operating cash flow also deserves attention, especially with capital spending rising modestly on a quarterly basis.
Management's outlook is directional rather than numerical. The filing says royalties are likely to decline in future quarters. Hardware sales are difficult to forecast because the contract with the U.S. government customer provides pricing but does not obligate the customer to purchase products until it issues purchase orders. The company also shut down its DSL service assurance software product line in 2013, and those results are reported as discontinued operations. Income from the patent arrangement remains unpredictable. On the spending side, research and development expense increased as engineering headcount grew from 30 employees at June 30, 2013 to 47 employees at June 30, 2014. Management says it will continue to focus research and development on enhancing existing products and developing new ones. That spending supports the strategy to sell more software into biometrics systems and projects, but it also raises the cost base.
The quarter showed strong demand across software licenses, services, and hardware. Operating margin expanded, and net income and EPS rose from the prior-year quarter. The year-to-date comparisons are less flattering because 2013 included patent arrangement income that did not repeat. The main risks are concentration in a single U.S. government hardware customer, a declining royalty stream, and the difficulty of predicting hardware demand. Operating cash flow fell sharply in the quarter and year to date, while deferred revenue declined. Those trends, along with the company's continued investment in engineering, are the key items to watch in coming quarters.
Forecast
No forward guidance in this quarter's filings.
Reported figures
GAAP, from SEC filings| Metric | Q2 FY2014 | Q1 FY2014 | QoQ | Q2 FY2013 | YoY |
|---|---|---|---|---|---|
| Revenue | $1.3M | $1.0M | +32.7% | $759.0K | +76.3% |
| Gross profit | $720.0K | $545.0K | +32.1% | $400.0K | +80.0% |
| Gross margin | 53.8% | 54.1% | -0.3 pp | 52.7% | +1.1 pp |
| Research & development | $1.4M | $1.3M | +9.5% | $1.5M | -6.4% |
| Sales & marketing | $981.0K | $858.0K | +14.3% | $972.0K | +0.9% |
| General & administrative | $975.0K | $804.0K | +21.3% | $928.0K | +5.1% |
| Total operating expenses | $5.4M | $5.3M | +1.5% | $4.6M | +17.9% |
| Net income (loss) | $865.0K | $880.0K | -1.7% | $307.0K | +181.8% |
| Net margin | 64.7% | 87.3% | -22.6 pp | 40.5% | +24.2 pp |
| Diluted EPS | $0.04 | $0.04 | ±$0.00 | $0.01 | +$0.03 |
Risks
Hardware sales are made to a single U.S. government customer, and the contract provides pricing but does not obligate the customer to purchase products until it issues purchase orders, making future hardware revenue difficult to forecast.
Software license and services revenue depend on winning biometrics systems projects with government customers or channel partners, and the six months ended June 30, 2014 lacked a license sale of the magnitude of the prior year's U.S. government agency sale.
Royalty payments under DSL silicon contracts have been declining, and the company believes it is likely that royalties will decline in future quarters.
Income from the patent monetization arrangement was recorded in the six months ended June 30, 2013 but was zero in the same period of 2014, and the company cannot predict whether future monetization efforts will produce income.
Summary, forecast, risks and KPIs are extracted from AWARE INC /MA/'s SEC filings for Q2 FY2014 (10-Q / 10-K and the 8-K earnings release); GAAP figures in the summary are checked against the reported XBRL data. They can contain errors; the filings are authoritative. Processed Nov 5, 2026.